Literature DB >> 28685209

Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Susanne Blank1, Thomas Schmidt2, Patrick Heger1, Moritz J Strowitzki1, Leila Sisic1, Ulrike Heger1, Henrik Nienhueser1, Georg Martin Haag3, Thomas Bruckner4, André L Mihaljevic1, Katja Ott5, Markus W Büchler1, Alexis Ulrich1.   

Abstract

BACKGROUND: The optimal surgical approach for adenocarcinoma directly at the esophagogastric junction (AEG II) is still under debate. This study aims to evaluate the differences between right thoracoabdominal esophagectomy (TAE) (Ivor-Lewis operation) and transhiatal extended gastrectomy (THG) for AEG II.
METHODS: From a prospective database, 242 patients with AEG II (TAE, n = 56; THG, n = 186) were included and analyzed according to characteristics and perioperative morbidity and mortality and overall survival (chi-square, Mann-Whitney U, log-rank, Cox regression).
RESULTS: Groups were comparable at baseline with exception of age. Patients older than 70 years were more frequently resected by THG (p = 0.003). No differences in perioperative morbidity (p = 0.197) and mortality (p = 0.711) were observed, including anastomotic leakages (p = 0.625) and pulmonary complications (p = 0.494). There was no significant difference in R0 resection (p = 0.719) and number of resected lymph nodes (p = 0.202). Overall median survival was 38.4 months. Survival after TAE was significantly longer than after THG (median OS not reached versus 33.6 months, p = 0.02). Multivariate analysis revealed pN-category (p < 0.001) and type of surgery (p = 0.017) as independent prognostic factors. The type of surgery was confirmed as prognostic factor in locally advanced AEG II (cT 3/4 or cN1), but not in cT1/2 and cN0 patients.
CONCLUSIONS: Our single-center experience suggests that patients with (locally advanced) AEG II tumors may benefit from TAE compared to THG. For further evaluation, a randomized trial would be necessary.

Entities:  

Keywords:  AEG II; Adenocarcinoma of the cardia; Ivor–Lewis operation; Thoracoabdominal esophagectomy; Transhiatal extended gastrectomy

Mesh:

Year:  2017        PMID: 28685209     DOI: 10.1007/s10120-017-0746-1

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  53 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.

Authors:  Luis F Tapias; Douglas J Mathisen; Cameron D Wright; John C Wain; Henning A Gaissert; Ashok Muniappan; Michael Lanuti; Dean M Donahue; Christopher R Morse
Journal:  Ann Thorac Surg       Date:  2015-12-01       Impact factor: 4.330

3.  Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial.

Authors:  Mitsuru Sasako; Takeshi Sano; Seiichiro Yamamoto; Motonori Sairenji; Kuniyoshi Arai; Taira Kinoshita; Atsushi Nashimoto; Masahiro Hiratsuka
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

Review 4.  Prognostic significance of positive circumferential resection margin in esophageal cancer: a systematic review and meta-analysis.

Authors:  Jie Wu; Qi-Xun Chen; Li-song Teng; Mark J Krasna
Journal:  Ann Thorac Surg       Date:  2013-12-21       Impact factor: 4.330

5.  Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.

Authors:  Yoshihiro Kakeji; Manabu Yamamoto; Shuhei Ito; Masahiko Sugiyama; Akinori Egashira; Hiroshi Saeki; Masaru Morita; Yoshihisa Sakaguchi; Yasushi Toh; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-01-14       Impact factor: 2.549

6.  Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?

Authors:  Hiromichi Ito; Thomas E Clancy; Robert T Osteen; Richard S Swanson; Raphael Bueno; David J Sugarbaker; Stanley W Ashley; Michael J Zinner; Edward E Whang
Journal:  J Am Coll Surg       Date:  2004-12       Impact factor: 6.113

Review 7.  Systematic review and meta-analysis of the influence of circumferential resection margin involvement on survival in patients with operable oesophageal cancer.

Authors:  D S Y Chan; T D Reid; I Howell; W G Lewis
Journal:  Br J Surg       Date:  2013-01-14       Impact factor: 6.939

8.  Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences.

Authors:  Jens Falk; Hanna Carstens; Lars Lundell; Maria Albertsson
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

9.  Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.

Authors:  Y Kurokawa; M Sasako; T Sano; T Yoshikawa; Y Iwasaki; A Nashimoto; S Ito; A Kurita; J Mizusawa; K Nakamura
Journal:  Br J Surg       Date:  2015-01-21       Impact factor: 6.939

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  19 in total

1.  Prolonged antibiotic prophylaxis after thoracoabdominal esophagectomy does not reduce the risk of pneumonia in the first 30 days: a retrospective before-and-after analysis.

Authors:  Marcel Hochreiter; Maria Uhling; Leila Sisic; Thomas Bruckner; Alexandra Heininger; Andreas Hohn; Katja Ott; Thomas Schmidt; Marc Moritz Berger; Daniel Christoph Richter; Markus Büchler; Markus Alexander Weigand; Cornelius Johannes Busch
Journal:  Infection       Date:  2018-06-05       Impact factor: 3.553

2.  Prediction of mediastinal lymph node metastasis in adenocarcinoma of the esophagogastric junction.

Authors:  Henrik Nienhüser; Thomas Schmidt
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

3.  Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.

Authors:  Akio Sakaki; Jun Kanamori; Koshiro Ishiyama; Daisuke Kurita; Junya Oguma; Hiroyuki Daiko
Journal:  Langenbecks Arch Surg       Date:  2020-06-08       Impact factor: 3.445

4.  Outcomes of the Surgical Treatment for Adenocarcinoma of the Cardia - Single Institution Experience.

Authors:  Stojan Potrc; Arpad Ivanecz; Bojan Krebs; Urska Marolt; Bojan Iljevec; Tomaz Jagric
Journal:  Radiol Oncol       Date:  2017-09-14       Impact factor: 2.991

5.  Diltiazem Prophylaxis for the Prevention of Atrial Fibrillation in Patients Undergoing Thoracoabdominal Esophagectomy: A Retrospective Cohort Study.

Authors:  Marcel Hochreiter; Thomas Schmidt; Benedikt H Siegler; Leila Sisic; Karsten Schmidt; Thomas Bruckner; Beat P Müller-Stich; Markus K Diener; Markus A Weigand; Markus W Büchler; Cornelius J Busch
Journal:  World J Surg       Date:  2020-07       Impact factor: 3.352

6.  Short-term postoperative complications and prognostic factors in patients with adenocarcinoma of the esophagogastric junction.

Authors:  Hui Zhang; WeiJian Zhang; DeFeng Peng; JinHai Zhu
Journal:  Thorac Cancer       Date:  2018-06-21       Impact factor: 3.500

Review 7.  Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.

Authors:  Jin-On Jung; Henrik Nienhüser; Nikolai Schleussner; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  RISK FACTORS FOR SEVERE POSTOPERATIVE COMPLICATIONS AFTER GASTRECTOMY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION CANCERS.

Authors:  Enrique Norero; Jose Luis Quezada; Jaime Cerda; Marco Ceroni; Cristian Martinez; Ricardo Mejía; Rodrigo Muñoz; Fernando Araos; Paulina González; Alfonso Díaz
Journal:  Arq Bras Cir Dig       Date:  2019-12-20

9.  Semi-embedded valve anastomosis a new anti-reflux anastomotic method after proximal gastrectomy for adenocarcinoma of the oesophagogastric junction.

Authors:  Baohua Wang; Yupeng Wu; Haijun Wang; Haiqiang Zhang; Liting Wang; Zhanxue Zhang
Journal:  BMC Surg       Date:  2020-10-08       Impact factor: 2.102

10.  Surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction: transthoracic or transabdominal? -a single-center retrospective study.

Authors:  Zi-Feng Yang; De-Qing Wu; Jun-Jiang Wang; Xing-Yu Feng; Jia-Bin Zheng; Wei-Xian Hu; Yong Li
Journal:  Ann Transl Med       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.